Bid Price | 3.80p | High Price | 4.68p |
---|
Ask Price | 4.80p | Low Price | 3.53p |
---|
Open Price | 3.68p | Spread | 20.83% |
---|
Prev Close | 4.31p | Volume | 43,775 |
---|
Proteome Sciences PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Jan 27, 2025 | 5.00 | 5.00 | 3.62 | 4.31 | 9,014 |
Jan 24, 2025 | 3.74 | 3.74 | 3.74 | 4.25 | 13,689 |
Jan 23, 2025 | 3.90 | 5.00 | 3.90 | 4.50 | 157,404 |
Jan 22, 2025 | 4.39 | 4.39 | 4.39 | 4.45 | 100,000 |
Jan 21, 2025 | 5.00 | 5.00 | 3.52 | 4.42 | 115,001 |
More Proteome Sciences PLC Historic Prices >Proteome Sciences PLC Information
Name | Proteome Sciences PLC | Index | FTSE AIM All Share |
---|
ISIN | GB0003104196 | Epic | PRM |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | AMSM |
---|
Industry | Diagnostics & Research | Sector | Healthcare |
---|
EMS | 100,000 | Trading Status | Closed |
---|
Shares in Issue | 295.18 m | Prev Close | 4.31p |
---|
PE Ratio | 17.428571 | Market Cap | £12.69 m |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | -£0.01 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | n/a | DPS Growth (%) | 0 |
---|
Current Ratio | 0.197156 | Quick Ratio | 0.138773 |
---|
Proteome Sciences PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
14/04/23 | BUY | Martin Diggle | NED | 100,000 @ £0.04 | £3,900.00 |
14/04/23 | BUY | Martin Diggle | NED | 100,000 @ £0.04 | £4,000.00 |
06/04/23 | BUY | Martin Diggle | NED | 100,000 @ £0.04 | £4,000.00 |
06/04/23 | BUY | Martin Diggle | NED | 14,766 @ £0.04 | £591.00 |
26/04/22 | BUY | Martin Diggle | NED | 91,906 @ £0.04 | £3,676.00 |
26/04/22 | BUY | Martin Diggle | NED | 91,906 @ £0.04 | £3,676.00 |
21/04/22 | BUY | Martin Diggle | NED | 732,500 @ £0.04 | £29,300.00 |
21/04/22 | BUY | Martin Diggle | NED | 732,500 @ £0.04 | £29,300.00 |
19/04/21 | BUY | Roger McDowell | NED | 900,000 @ £0.05 | £45,000.00 |
14/04/21 | BUY | Richard Dennis | ED | 125,000 @ £0.05 | £6,613.00 |
More Proteome Sciences PLC Director Deals >Proteome Sciences PLC News